Capital City Email
Search League Tables

Thursday, 24 April 2014


What’s New at IFR

IFR Magazine now available on iPAD and iPHONE

IFR Magazine subscribers can now access the latest edition on their Apple iPad® and iPhone® devices. Search for ‘IFR Magazine’ in the Apple App Store or click here to download the app, and contact for your login details.

CapCity IFRe’s rolling digest of news, comment, and pure capital markets banter. CapCity will provide short, sharp takes from the Thomson Reuters stable — with links to news sources around the world and a discerning filter of social media. You will also get early tastes of the deep news and analysis featured in the weekly International Financing Review and our daily capital markets briefings.

Click here to enter Capital City

Expanded Commentary

Expanded Commentary

Thought-provoking industry intelligence, with unique insight into important news and moves on the Capital Markets and throughout the financial world. The team includes IFR Editor-at-Large Keith Mullin and expert industry contributors such as SwissInvest Strategist Anthony Peters.

Click here for the latest range of Commentaries and Blogs

IFR US ECM Briefing

US ECM Briefing

The IFR US ECM Briefing joins its European and Asian counterparts to complete a global set of daily reports dedicated to the Equity Capital Markets. The Briefing is essential reading for ECM bankers – both in the US and throughout the world – as well as lawyers, advisers and investors who need to know what is driving the world’s most important market for raising equity capital.

For more information, including subscription/trial details, click here

IFR India Capital Markets Briefing

India Capital Markets Briefing

The IFR India Capital Markets Briefing combines all the significant news, commentary and transactional data covering the international and domestic markets for debt and equity to give deal originators, syndicators and investors the insight they need to understand one of the most dynamic of today’s markets.

For more information, including subscription/trial details, click here